Physician

Michael Rozak, MD

According to 2025 Medicare claims, Michael Rozak, MD (NPI: 1295199826) practices pain management in the Punta Gorda, FL market, with the plurality of this provider's patient population coming from Charlotte, FL. This provider's primary affiliated billing organization is SW FLORIDA PAIN CENTER INC (NPI: 1215006549; TIN: 650797144) and primary practice location at 33948-2070.

Rozak's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 780 traditional Medicare patients, billed 28,976 HCPCS/CPT codes, and received $389,968 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 2,077 prescription claims across 424 beneficiaries totaling $64,282 in drug costs, led by Movantik (Naloxegol Oxalate). Open Payments data shows 25 records totaling $1,197. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $1,982 to $64,282. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$195K$390K2021 Medicare payment: $28,008 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $173,237 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $296,029 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $389,968 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202190309$28,008
20223752,120$173,237
20235577,401$296,029
202478028,976$389,968

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$32K$64K2016 Drug cost: $1,982 (USD; Tot_Drug_Cst)2017 Drug cost: $3,081 (USD; Tot_Drug_Cst)2018 Drug cost: $2,321 (USD; Tot_Drug_Cst)2019 Drug cost: $226 (USD; Tot_Drug_Cst)2020 Drug cost: $1,828 (USD; Tot_Drug_Cst)2021 Drug cost: $6,599 (USD; Tot_Drug_Cst)2022 Drug cost: $26,966 (USD; Tot_Drug_Cst)2023 Drug cost: $49,904 (USD; Tot_Drug_Cst)2024 Drug cost: $64,282 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161742$1,982
20172551$3,081
20181985$2,321
2019N/R17$226
20201540$1,828
202181226$6,599
20221951,128$26,966
20232611,737$49,904
20244242,077$64,282

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more311414$69
80307Testing for presence of drug, by chemistry analyzers144158$61
J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg1681,188$1
Q9966Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml134518$0
J1010Injection, methylprednisolone acetate, 1 mg18920,613$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MovantikNaloxegol Oxalate21630$8,301
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen2156,302$8,275
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen35410,029$7,859
Oxycodone HclOxycodone Hcl2255,804$4,750
GabapentinGabapentin1626,612$3,281

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.25$1,197Nevro Corp.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael Rozak, MD?

Tedicare shows public-source Medicare data for Michael Rozak, MD (NPI 1295199826), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Rozak, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Rozak, MD?

Michael Rozak, MD is linked to SW FLORIDA PAIN CENTER INC (billing NPI 1215006549) in the available physician profile data.

Does Michael Rozak, MD have Open Payments data?

Michael Rozak, MD has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.